http://dbpedia.org/ontology/abstract
|
Omiloxetine (omiloextinum, omiloxetino INN … Omiloxetine (omiloextinum, omiloxetino INN) was a selective serotonin reuptake inhibitor drug candidate that underwent preclinical development by the Spanish pharmaceutical company, Ferrer Internacional, until 2005, when it was abandoned. Rafael Foguet also patented .s abandoned. Rafael Foguet also patented .
|
http://dbpedia.org/ontology/casNumber
|
176894-09-0
|
http://dbpedia.org/ontology/chEMBL
|
2105290
|
http://dbpedia.org/ontology/fdaUniiCode
|
H8YI0SSF7B
|
http://dbpedia.org/ontology/pubchem
|
3047803
|
http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Omiloxetine.svg?width=300 +
|
http://dbpedia.org/ontology/wikiPageID
|
35874308
|
http://dbpedia.org/ontology/wikiPageLength
|
3177
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1084239746
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Selective_serotonin_reuptake_inhibitors +
, http://dbpedia.org/resource/Category:Phenethylamines +
, http://dbpedia.org/resource/Category:Fluoroarenes +
, http://dbpedia.org/resource/Category:Benzodioxoles +
, http://dbpedia.org/resource/International_Nonproprietary_Name +
, http://dbpedia.org/resource/Abaperidone +
, http://dbpedia.org/resource/Category:4-Phenylpiperidines +
, http://dbpedia.org/resource/Category:Ketones +
, http://dbpedia.org/resource/Selective_serotonin_reuptake_inhibitor +
|
http://dbpedia.org/property/atcPrefix
|
None
|
http://dbpedia.org/property/boilingPoint
|
587.2
|
http://dbpedia.org/property/c
|
27
|
http://dbpedia.org/property/casNumber
|
176894
|
http://dbpedia.org/property/chembl
|
2105290
|
http://dbpedia.org/property/chemspiderid
|
2310120
|
http://dbpedia.org/property/density
|
1.3
|
http://dbpedia.org/property/f
|
2
|
http://dbpedia.org/property/h
|
25
|
http://dbpedia.org/property/iupacName
|
2
|
http://dbpedia.org/property/meltingPoint
|
228.65
|
http://dbpedia.org/property/n
|
1
|
http://dbpedia.org/property/o
|
4
|
http://dbpedia.org/property/pubchem
|
3047803
|
http://dbpedia.org/property/smiles
|
Fc1cccCCN3CC[C@H][C@H]COc4ccc5OCOc5c4
|
http://dbpedia.org/property/solubility
|
0.0015
|
http://dbpedia.org/property/stdinchi
|
1
|
http://dbpedia.org/property/stdinchikey
|
FAHGZANUNVVDFL-HYBUGGRVSA-N
|
http://dbpedia.org/property/unii
|
H8YI0SSF7B
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Nervous-system-drug-stub +
, http://dbpedia.org/resource/Template:Antidepressants +
, http://dbpedia.org/resource/Template:Monoamine_reuptake_inhibitors +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Fluoroarenes +
, http://dbpedia.org/resource/Category:4-Phenylpiperidines +
, http://dbpedia.org/resource/Category:Ketones +
, http://dbpedia.org/resource/Category:Selective_serotonin_reuptake_inhibitors +
, http://dbpedia.org/resource/Category:Phenethylamines +
, http://dbpedia.org/resource/Category:Benzodioxoles +
|
http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Candidate +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Omiloxetine?oldid=1084239746&ns=0 +
|
http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Omiloxetine.svg +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Omiloxetine +
|
owl:sameAs |
http://rdf.freebase.com/ns/m.0jwrtd5 +
, https://global.dbpedia.org/id/4sfhZ +
, http://dbpedia.org/resource/Omiloxetine +
, http://yago-knowledge.org/resource/Omiloxetine +
, http://www.wikidata.org/entity/Q7090187 +
, http://sh.dbpedia.org/resource/Omiloksetin +
, http://sr.dbpedia.org/resource/Omiloksetin +
|
rdf:type |
http://dbpedia.org/class/yago/WikicatSelectiveSerotoninReuptakeInhibitors +
, http://dbpedia.org/class/yago/CausalAgent100007347 +
, http://dbpedia.org/class/yago/Inhibitor114724436 +
, http://dbpedia.org/class/yago/Message106598915 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Substance100020090 +
, http://dbpedia.org/class/yago/WikicatAntidepressants +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/class/yago/Drug103247620 +
, http://dbpedia.org/class/yago/Agent114778436 +
, http://dbpedia.org/class/yago/MolecularFormula106817173 +
, http://dbpedia.org/class/yago/Formula106816935 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/WikicatMolecularFormulas +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/Antidepressant102718811 +
, http://dbpedia.org/class/yago/Statement106722453 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/Medicine103740161 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Communication100033020 +
, http://dbpedia.org/ontology/Person +
|
rdfs:comment |
Omiloxetine (omiloextinum, omiloxetino INN … Omiloxetine (omiloextinum, omiloxetino INN) was a selective serotonin reuptake inhibitor drug candidate that underwent preclinical development by the Spanish pharmaceutical company, Ferrer Internacional, until 2005, when it was abandoned. Rafael Foguet also patented .s abandoned. Rafael Foguet also patented .
|
rdfs:label |
Omiloxetine
|